Mimedx (MDXG) Long-Term Investments (2014 - 2015)
Mimedx's (MDXG) quarterly Long-Term Investments came in at $2.5 million in Q1 2015, down 23.08% quarter-over-quarter from $3.2 million in Q4 2014.
Analysis
Mimedx (MDXG) Long-Term Investments (2014 - 2015) Analysis & Trends
Mimedx has disclosed Long-Term Investments across 2 years of filings, most recently posting $2.5 million for Q1 2015.
- In Q1 2015, Long-Term Investments changed N/A year-over-year to $2.5 million; the TTM figure through Mar 2015 stood at $2.5 million (changed N/A YoY), while the FY2014 annual figure was $3.2 million, changed N/A from the prior year.
- Long-Term Investments came in at $2.5 million for Q1 2015 at Mimedx, down from $3.2 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $3.2 million in Q4 2014 to a low of $2.5 million in Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 3.41 Bn |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | 2.25 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 244.10 Mn |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | - |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | - |
| 10 | Mimedx | 667.30 Mn | 531.46 Mn | 44.38 Mn | - |